Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions

被引:65
作者
Ho, ML [1 ]
Chang, JK
Chuang, LY
Hsu, HK
Wang, GJ
机构
[1] Kaohsiung Med Coll, Dept Physiol, Kaohsiung, Taiwan
[2] Kaohsiung Med Coll, Dept Orthopaed, Kaohsiung, Taiwan
[3] Kaohsiung Med Coll, Dept Biochem, Kaohsiung, Taiwan
[4] Univ Virginia, Hlth Sci Ctr, Dept Orthopaed, Charlottesville, VA USA
关键词
osteoblast; rat calvarium; NSAID; prostaglandin; proliferation; differentiation;
D O I
10.1016/S0006-2952(99)00186-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been reported that nonsteroidal anti-inflammatory drugs (NSAIDs) suppress bone repair and bone remodeling but only mildly inhibit bone mineralization at the earlier stage of the repair process. We proposed that the proliferation and/or the earlier stage of differentiation of osteoblasts may be affected by NSAIDs. This study was designed to investigate whether NSAIDs affect the proliferation and/or differentiation of osteoblasts and whether these effects are prostaglandin (PG) mediated. The effects of PGE, and PGE,, indomethacin, and ketorolac on thymidine incorporation, cell count, intracellular alkaline phosphatase (ALP) activity, and Type I collagen content in osteoblast-enriched cultures derived from fetal calvaria were evaluated. The results showed that both PGs and NSAIDs inhibited DNA synthesis and cell mitosis in a time- and concentration-dependent manner. However, intracellular ALP activity and Type I collagen content were stimulated at an earlier stage of differentiation in osteoblasts. These results suggested that (i) the inhibitory effect of ketorolac on osteoblastic proliferation contributes to its suppressive effects on bone repair and remodeling in vivo; (ii) PGEs and NSAIDs may be involved in matrix maturation and biologic bone mineralization in the earlier stage of osteoblast differentiation; and (iii) the effects of ketorolac and indomethacin on cell proliferation and differentiation may not be through the inhibition of the synthesis of PGE, or PGE,. BIOCHEM PHARMACOL 58;6:983-990, 1999. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:983 / 990
页数:8
相关论文
共 51 条
[1]   INDOMETHACIN AND ASPIRIN - EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY AGENTS ON THE RATE OF FRACTURE REPAIR IN THE RAT [J].
ALLEN, HL ;
WASE, A ;
BEAR, WT .
ACTA ORTHOPAEDICA SCANDINAVICA, 1980, 51 (04) :595-600
[2]   A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes [J].
Arber, N ;
Han, EKH ;
Sgambato, A ;
Piazza, GA ;
Delohery, TM ;
Begemann, M ;
Weghorst, CM ;
Kim, NH ;
Pamukcu, R ;
Ahnen, DJ ;
Reed, JC ;
Weinstein, IB ;
Holt, PR .
GASTROENTEROLOGY, 1997, 113 (06) :1892-1900
[3]   FACTORS THAT PROMOTE PROGRESSIVE DEVELOPMENT OF THE OSTEOBLAST PHENOTYPE IN CULTURED FETAL-RAT CALVARIA CELLS [J].
ARONOW, MA ;
GERSTENFELD, LC ;
OWEN, TA ;
TASSINARI, MS ;
STEIN, GS ;
LIAN, JB .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 143 (02) :213-221
[4]  
BESSEY OA, 1946, J BIOL CHEM, V164, P321
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   TGF-BETA ALTERS GROWTH AND DIFFERENTIATION-RELATED GENE-EXPRESSION IN PROLIFERATING OSTEOBLASTS IN-VITRO, PREVENTING DEVELOPMENT OF THE MATURE BONE PHENOTYPE [J].
BREEN, EC ;
IGNOTZ, RA ;
MCCABE, L ;
STEIN, JL ;
STEIN, GS ;
LIAN, JB .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 160 (02) :323-335
[7]   KETOROLAC - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL [J].
BUCKLEY, MMT ;
BROGDEN, RN .
DRUGS, 1990, 39 (01) :86-109
[8]   DIFFERENTIAL ACTIONS OF PROSTAGLANDINS IN SEPARATE CELL-POPULATIONS FROM FETAL-RAT BONE [J].
CENTRELLA, M ;
CASINGHINO, S ;
MCCARTHY, TL .
ENDOCRINOLOGY, 1994, 135 (04) :1611-1620
[9]  
CENTRELLA M, 1987, J BIOL CHEM, V262, P2869
[10]   STIMULATION OF BONE-FORMATION BY PROSTAGLANDIN-E2 [J].
CHYUN, YS ;
RAISZ, LG .
PROSTAGLANDINS, 1984, 27 (01) :97-103